250 Mg Lapatinib Tablets IP

Name: 250 Mg Lapatinib Tablets IP
Brand: NEETCO BIOPHARMA
Price: 1990 INR
Availability: InStock

Price 1990 INR/ Bottle

Get a Price/Quote

MOQ : 1 Bottle

250 Mg Lapatinib Tablets IP Specification

Dosage Form
Film-coated tablets

Salt Composition
Lapatinib

Indication
HER2-positive metastatic or advanced breast cancer in combination with other medicines

Pacakaging (Quantity Per Box)
30 tablets

Origin of Medicine
India

Drug Type
Allopathic

Ingredients
Lapatinib

Physical Form
Tablet

Function
Tyrosine kinase inhibitor; anti-cancer agent

Recommended For
Breast cancer (HER2-positive)

Dosage
250 mg per tablet; dosage to be determined by a healthcare professional

Dosage Guidelines
Take as prescribed by physician, typically once daily

Suitable For
Adults

Quantity
30 tablets per box

Storage Instructions
Store below 30C, protected from moisture and light

About 250 Mg Lapatinib Tablets IP

Discover the venerable paragon of cancer therapy with 250 Mg Lapatinib Tablets IP. Superb in efficacy, these film-coated, yellow oval tablets are expertly crafted by a local pharmaceutical manufacturer (check packaging for details). Designed for HER2-positive breast cancer, their molecular formula (C29H26ClFN4O4S) and DCGI approval set a superb benchmark in oncology care. Find limited stock available-get it now while supplies last. Each box contains 30 tablets, with prescription-only access. Store below 30C, protected from moisture and light, and follow your physician's dosage for optimal results.

Extra Features & Uses of 250 Mg Lapatinib Tablets IP

These tablets stand out with their superb film-coated design and trusted efficacy for HER2-positive metastatic or advanced breast cancer. Used orally, each tablet delivers 250 mg of lapatinib, acting as a potent tyrosine kinase inhibitor to suppress tumor growth. Recommended for adult patients, they are suitable both as a prime anti-cancer agent and in combination therapies, ensuring robust therapeutic outcomes when prescribed adeptly by your healthcare provider.

FOB Port, Export Markets & Sample Policy for 250 Mg Lapatinib Tablets IP

Transport services for 250 Mg Lapatinib Tablets IP frequently depart from major Indian freight ports. We offer international delivery, catering primarily to export markets in Asia, Africa, and the Middle East. Samples can be provided, subject to our established sample policy, to enable clients to review quality before placing bulk orders. Efficient freight handling ensures safe transit under optimal conditions, maintaining drug integrity throughout the journey.

FAQ's of 250 Mg Lapatinib Tablets IP:

Q: How should 250 Mg Lapatinib Tablets IP be used?

A: 250 Mg Lapatinib Tablets IP should be taken orally, typically once daily, exactly as prescribed by your physician. Do not alter the dosage without medical guidance.

Q: What are the primary benefits of using Lapatinib tablets?

A: The primary benefit of Lapatinib tablets is their proven efficacy as a tyrosine kinase inhibitor in managing HER2-positive metastatic and advanced breast cancer, particularly in combination with other therapies.

Q: When should I avoid taking these tablets?

A: Avoid taking 250 Mg Lapatinib Tablets IP if you have hypersensitivity to lapatinib or any of the tablet's components. Should allergic reactions occur, contact your physician immediately.

Q: Where are these tablets manufactured and shipped from?

A: These tablets are manufactured in India by a local pharmaceutical producer. Shipments typically depart from India's principal freight ports to reach international markets.

Q: What is the process for obtaining a sample of 250 Mg Lapatinib Tablets IP?

A: Samples are offered based on our sample policy. Please contact our distribution or export team to inquire about eligibility and specific protocols for sample requests.

Q: Who determines the precise dosage for each patient?

A: The precise dosage of 250 Mg Lapatinib Tablets IP is determined by a licensed healthcare professional, tailored to the individual patient's condition and therapeutic response.

Tell us about your requirement